Altered sphingolipid metabolism induced by tumor hypoxia - new vistas in glycolipid tumor markers

FEBS Lett. 2010 May 3;584(9):1872-8. doi: 10.1016/j.febslet.2009.11.019. Epub 2009 Nov 11.

Abstract

Uncontrolled growth of malignant cells produces hypoxic regions in locally advanced tumors. Recently we showed that tumor hypoxia-induced transcription of multiple genes involved in glycan synthesis, leading to expression of useful glycolipid tumor markers, such as gangliosides having N-glycolyl sialic acid. Our subsequent studies indicated that the ceramide portion of glycolipids, as well as their glycan moiety, was also significantly affected by hypoxia. Tumor hypoxia-induced marked accumulation of sphinganine (dihydrosphingosine) long-chain base, and significant reduction of unsaturated very long-chain fatty acids in the ceramide moiety. Mass-spectrometry, which yields information on both glycan- and ceramide moieties, is expected to be clinically useful in detecting such distinct molecular species of cancer-associated glycolipids having combined alteration in both glycan- and ceramide moieties.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / metabolism*
  • Ceramides / analysis
  • Ceramides / metabolism
  • Gene Expression Regulation, Neoplastic / physiology
  • Glycolipids / analysis
  • Glycolipids / metabolism
  • Humans
  • Hypoxia / complications*
  • Hypoxia / genetics
  • Hypoxia / metabolism
  • Lipid Metabolism Disorders / etiology*
  • Mass Spectrometry / methods
  • Models, Biological
  • Neoplasms / complications*
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Sphingolipids / analysis
  • Sphingolipids / metabolism*

Substances

  • Biomarkers, Tumor
  • Ceramides
  • Glycolipids
  • Sphingolipids